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Abstract
Over the past 10 years, several instruments developed specifically for the assessment of Quality of
Life (QOL) in dementia have been introduced. The goal of the current review is to present,
compare, and critique existing QOL measures for dementia populations to assist investigators and
clinicians in selecting the optimal inventory for their specific needs. Nine measures are reviewed
with a focus on conceptualizations of QOL, psychometric data, targeted patient population, and
administration and scoring procedures. Critical discussion and comparison of the instruments is
presented after the scales are described individually. Differences in definitions of QOL, assessment
procedures, and methods that were used to establish the validity of instruments are highlighted.
An important direction for future research on QOL scales for dementia is to establish their
responsiveness to change over time. It will also be important to identify factors that affect reports
of QOL, determine the how perceived QOL affects decisions regarding the care of dementia
patients, and evaluate interventions to increase patient QOL.
Introduction
Quality of Life measures for dementia
Over the past 10 years, experts in the field of dementia
have increasingly turned their attention to consideration
of patient Quality of Life (QOL). The importance of meas-
uring QOL outcomes in clinical trials and for the clinical
management of dementia was debated and discussed
among leaders in dementia research and treatment, the
pharmaceutical industry, and government agencies [1,2].
Efforts to define, quantify, and systematically measure
QOL in dementia resulted in the development of several
new measures. These measures vary widely across several
important domains but a unifying theme is the influence
that Lawton's model of QOL in dementia [3–5] had on
conceptualization of QOL. This paper will review existing
measures of QOL developed specifically for dementia
populations. Conceptualizations, psychometric data, and
administration and scoring procedures of the measures
will be presented.
After the instruments are individually described and re-
viewed, they will be compared and critiqued. Discussion
will focus on several critical dimensions that vary between
QOL instruments. For example, some authors employ
definitions of QOL that include a broad range of signs and
symptoms that impact daily life, such as cognitive func-
tioning, performance of activities of daily living (ADLs),
and social and psychological factors, whereas other inves-
tigators designed scales to be much more narrow in focus.
Instruments also differ as to the type and severity of de-
mentia populations that were used in validation and reli-
ability studies, and whether or not patients themselves or
a proxy responds to items on the inventory.
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Despite the introduction of several measures of QOL for
dementia populations in recent years, there continues to
be some confusion about what types of instruments
should be considered QOL measures in dementia. For ex-
ample, ADL and depression inventories have been classi-
fied as QOL measures [6,7]. Operational definitions of
QOL in dementia are clearly needed to help clarify the
boundaries between QOL measures and other outcome
measures of dementia, such as neuropsychiatric symp-
toms and cognitive impairment. The goal of this review is
to increase awareness of existing instruments and to high-
light important distinctions among measures to help fu-
ture investigators and clinicians select the most
appropriate instrument for their purposes.
Measures included in this review have been developed for
use with Alzheimer's disease (AD) patients or with mixed
dementia populations. Instruments developed specifical-
ly for assessment of QOL in Parkinson's disease are ex-
cluded because they have been recently reviewed
elsewhere (see references section [8]).
Generic and health-related QOL measures are beyond the
scope of this review, although they have been adapted for
use with dementia populations in some studies [9,10].
Generic measures are useful for comparative studies
across different disease states and populations. However,
they are not specifically tailored for dementia populations
and thus may not fully capture unique and important as-
pects of dementia patients' experiences. For example, ge-
neric QOL measures may not assess enjoyment of
activities, feelings and mood, or response to surroundings
[11]. Furthermore, generic inventories assess many symp-
toms of physical illness that are unrelated to dementia.
Thus, generic QOL scales are unlikely to be the most sen-
sitive and specific measures of domains of QOL that are
relevant to dementia patients.
Method
Literature Review
The literature on dementia and QOL was reviewed from
1966 to 2002. Medline and PsychINFO lit searches were
conducted using the following key words in various com-
binations: quality of life, well-being, dementia, Alzheim-
er's disease, instrument, assessment, measurement, and
questionnaire. Reference lists in publications that meas-
ured QOL in dementia populations also were included in
the literature search. All articles that reported on the devel-
opment and psychometric properties of an instrument
that was designed to measure QOL in dementia were re-
viewed. As stated in the introduction, generic QOL meas-
ures and scales developed specifically for use with
Parkinson's disease patients were excluded.
Results
Fourteen articles regarding nine different dementia QOL
scales were identified and reviewed. Characteristics of the
QOL scales are reviewed in Table 1 (see Additional file: 1),
which includes the following measures: Albert et al.'s Af-
fect and Activity Ratings [12,13], Alzheimer Disease Relat-
ed Quality of Life (ADRQL [11]), Cornell-Brown Scale for
Quality of Life (CBS [14]), Dementia Care Mapping
(DCM [15–17]), Dementia Quality of Life (DQoL [18]),
Psychological Well-Being in Cognitively Impaired Persons
(PWB-CIP [7,19]), Quality of Life in Late-Stage Dementia
(QUALID) Scale [20], Quality of Life-Alzheimer's Disease
(QOL-AD [21,22]), and the Quality of Life Assessment
Schedule (QOLAS [23]). The instruments were developed
between 1992 and 2002.
Activity and Affect Indicators of QOL [12,13]
Albert et al. created a measure of QOL that incorporates
assessment of patients' activity and affect. These domains
were measured because they are observable, quantifiable,
behavioral, and they were hypothesized to be indicators
of subjective, internal states of patients [12]. A strength of
this measure is that it is appropriate for use with a broad
range of patients, from mild to severe stages of dementia
severity. Furthermore, the measures can be used in both
institutional and home-care settings. A potential draw-
back of this inventory is that it provides a fairly narrow
measurement of QOL that is confined to two dimensions,
activity and affect.
Fifteen activity items were selected from Teri and
Logsdon's Pleasant Events Schedule-AD [24,25]. Activity
items vary from simple to complex, and they occur both
inside and outside of the home. Proxies rate the frequency
for each activity within a 1-week time frame and these fre-
quency counts are summed. For the affect measure, six af-
fects were selected from Lawton's Affect Rating scale [26]
to include both positive and negative affect and that could
be easily recognized in body and facial expressions: pleas-
ure, anger, anxiety, depression, interest, and contentment.
Affects are coded for frequency during the past 2 weeks on
a 5-point scale, ranging from never to greater than or
equal to 3 times per day. Summary scores for positive and
negative affect are calculated [13].
To assess the reliability and validity of the measure, tele-
phone interviews were conducted with caregivers of 130
AD patients. One-week test-retest reliability ranged from
.53 to .92 for the affect items (Mdn = .77) and was above
.60 for 12 of 15 activity frequency items. No systematic
differences in QOL reports were found between family
and institutional caregivers.
Validity of the scale was indicated by a significant correla-
tion between activity and the modified Mini-Mental StateHealth and Quality of Life Outcomes 2003, 1 http://www.hqlo.com/content/1/1/11
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Examination (mMMS [27]) scores, indicating that activity
decreased as dementia severity increased. Affect measures
showed variable associations with dementia severity. An
overall QOL composite was created by considering high
activity frequency, high positive affect, and low negative
affect as indicative of higher QOL [12].
Alzheimer Disease Related Quality of Life (ADRQL) [11]
The ADRQL was developed to assess domains that car-
egivers of AD patients and AD experts identified as impor-
tant for health-related QOL in dementia. Scale
development was guided by focus groups and expert pan-
els. The scale measures both positive and negative behav-
iors across five domains: Social Interaction, Awareness of
Self, Feelings and Mood, Enjoyment of Activities, and Re-
sponse to Surroundings. The majority of items measure
observable behaviors and actions, although some rely on
assessment of subjective and internal states. Caregiver re-
spondents are used for the ADRQL. Scores are calculated
using a preference-based weighting approach, where
weights for QOL indicators differ according to the impor-
tance of the domain. Weights were calculated from ratings
of 61 caregivers, who were asked to rank each item as to
its importance for QOL on a 1 to 10 scale. This scale
promises to offer a comprehensive assessment of QOL
across several important domains. However, a the current
time, we are not aware of any published data regarding the
psychometric characteristics of this scale. Furthermore, it
is not clear if the scale is adaptable for use in both home-
care and institutional settings, or for what level of demen-
tia severity the scale was developed. Additional data are
need in order to accurately assess the strengths and weak-
nesses of this measure.
The Cornell-Brown Scale for Quality of Life in Dementia 
(CBS) [14]
The CBS provides a global assessment of QOL. The scale
was developed based on the conceptualization that high
QOL is indicated by the presence of positive affect, physi-
cal and psychological satisfactions, self-esteem and the
relative absence of negative affect and experiences. Initial
psychometric evidence has been obtained from patients
in the mild to moderate stages of dementia severity, who
are still living at home.
The CBS was developed by modifying the Cornell scale for
Depression in Dementia in two ways [28,29]. First, to
measure positive aspects of QOL, the Cornell scale items
were broadened to include assessment of positive emo-
tions, experiences, and satisfactions. Second, the rating
scale for each item was altered to range from -2 (negative
pole anchor) to +2 (positive pole anchor). Total CBS
scores can range from -38 to +38. Negative scores indicate
that negative ratings of mood, behavior, physical signs,
ideational disturbance, and cyclic functions outweigh
positive ratings. Thus, the more negative the score, the
poorer the QOL rating. Positive scores are obtained when
positive ratings outweigh negative ratings and indicate
higher QOL.
A strength of the CBS is that it incorporates patient and
caregiver perspectives into one rating. The CBS is rated by
a clinician after a joint interview with the patient and car-
egiver. Separate interviews and ratings can be made with
patients and caregivers but initial psychometric data are
based only on results of joint interviews. The interview is
semi-structured and the time-frame covers the previous
month.
Preliminary reliability and validity studies were conduct-
ed on data collected from joint interviews with 50 demen-
tia patients and knowledgeable informants. All patients
had an MMSE of 9 or greater. Results indicated that the
scale has adequate interrater reliability (intraclass r = .90)
and internal consistency (Cronbach's alpha = .81). Crite-
rion validity was indicated by a positive correlation be-
tween CBS scores and visual analogue positive mood
ratings made by patients (Spearman rho = .63). QOL was
negatively correlated with dementia severity as measured
by the Clinical Dementia Rating scale (rho = -.35). Relia-
bility and validity findings were similar for the more mild-
ly and more severely impaired halves of the sample.
Dementia Care Mapping (DCM) [15–17]
DCM is a structured, observational assessment of demen-
tia patient experiences that was introduced in 1992 [17].
DCM was developed for use in residential care settings
with dementia patients who are unable to provide valid
and reliable reports about their experiences [16]. Thus, it
is most appropriate for use with moderate to severely im-
paired patients. Patient well-being and activities are coded
with an emphasis on behaviors that are hypothesized to
be related to QOL. Well-versus ill-being of patients is rat-
ed on a 6-point ordinal scale and ratings are based on
signs from patients and on the behavior of staff towards
the patient. There are 24 activity rating categories and in-
dicators of social withdrawal also can be coded [15].
A strength of the DCM that it is an intensive assessment
method that typically requires observers to rate indicators
of patients' QOL every five minutes over a 6-hour time
frame, although differing time frames have been used
[17]. For example, a one-hour assessment was significant-
ly correlated (p < .05) with the full-length assessment for
activities (r = .68) and well-ill being (r = .50) [15]. This
shorter observation period may be more practical for in-
vestigators who have limited time and funds.
In analyses of data collected from residential and nursing
home facilities (N = 177), results indicated that activityHealth and Quality of Life Outcomes 2003, 1 http://www.hqlo.com/content/1/1/11
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and well-ill being scores were significantly correlated (rs =
|.16 to .63|, Mdn = .53), indicating internal consistency of
the measure [15]. One- to four-week test-retest reliability
for 54 patients indicated good reliability for well-ill being
scores (r = .55) and moderate reliability for activities (r =
.40) and social withdrawal (r = .43) [15].
Validity was indicated by agreement between DCM scores
and quality assurance audit measures of residential nurs-
ing care [16]. Concurrent validity was indicated by a sig-
nificant (p < .001) correlation of well-ill being scores with
a pencil and paper, generic measure of QOL [30] for a sub-
set of 19 patients (r = .73), but activities did not correlate
significantly with the QOL measure (r = .29). DCM has
high face validity as indicated by a staff acceptability as-
sessment [16].
Dementia Quality of Life Instrument (DQoL) [18]
The DQoL [18] was developed through an iterative con-
ceptual and statistical process that included a literature re-
view and consultation with expert panels composed of
dementia patients, caregivers, and professional care pro-
viders. It is a 29-item scale, plus one global item ("Overall,
how would you rate your quality of life?") that measures
5 domains of QOL: Positive Affect (6 items), Negative Af-
fect (11 items), Feelings of Belonging (3 items), Self-es-
teem (4 items), and Sense of Aesthetics (5 items). The
DQoL yields scores on 5 subscales but subscale scores are
not summed to reach an overall or global measure of
QOL.
The scale is unique because it is the only scale developed
exclusively to be administered to patients. Item-stems
were made as simple as possible and a 5-point visual scale
is used to present multiple choice response choices to pa-
tients. All points on the response scale are associated with
verbal descriptors. Screening questions ensure that pa-
tients understand questionnaire instructions and the re-
sponse format for the scale. Because it relies solely on
patient-input, the DQoL is appropriate for use with pa-
tients in the mild to moderate stages of dementia.
In a sample of 99 patients diagnosed with mild to moder-
ate dementia (MMSE ranged from 12 to 21), only 4% of
participants could not correctly answer the screening
questions and thus were not administered the entire scale.
For patients who completed the DQoL, internal consist-
ency reliabilities for subscales were moderate to high (.67
to .89; Mdn = .80). There were no significant differences
between patient groups with mild (MMSE > 17) and mod-
erate (MMSE <= 17) dementia severity in terms of scale re-
liability. Two-week test-retest reliability for a subset of
participants (n = 18) ranged from .64 to .90 (Mdn = .72).
Convergent validity was indicated by correlations with
scores on the Geriatric Depression Scale and 4 DQoL sub-
scales (r = -.48 self-esteem, r = -.61 positive affect, r = -.64
absence of negative affect, r = -.42 feelings of belonging)
[18]. The instrument takes approximately 10 minutes to
administer.
Psychological Well-Being in Cognitively Impaired Persons 
(PWB-CIP) [7,19]
The PWB-CIP measures aspects of QOL related to psycho-
logical well-being. It is an observer-rated, 11-item scale
that measures positive and negative affective states and
engagement behaviors [7]. It has been used with dementia
patients in the mild to moderate stages of severity, who
are being cared for at home. A strength of the scale is that
some longitudinal data are available regarding its psycho-
metric properties. Furthermore, it is an observer-rated
scale and thus it is more appropriate for use with patients
with greater dementia severity, relative to scales that rely
on patient input. A drawback of the scale is that it is a rel-
atively narrow measure of QOL, focusing only on affect
and behavior.
Factor analysis on data gathered from 96 caregivers of de-
mentia outpatients revealed three subscales: Frustrated/
Agitated, Positive Interaction, and Discontent Expressions
[19]. Internal consistency reliability for all three subscales
was strong at baseline (alpha = .79, .74, and .66, respec-
tively) and at an 18-month follow-up assessment (alphas
= .75, .83, .68, respectively). Total scale internal reliability
was .81 at baseline and .82 at the follow-up. Validity was
indicated by significant (p < .01) correlations between to-
tal PWB-CIP scores and measures of depression, personal-
ity, social behavior, functional ability, problem solving,
and task orientation at baseline and 18-month follow-up.
The Quality of Life in Late-Stage Dementia (QUALID) 
Scale [20]
The QUALID was created by selecting a subset of items
from Albert et al.'s affect and activity measures [12] to be
used specifically with late-stage dementia patients in insti-
tutional settings. A strength of the scale is its brevity. It is
a proxy-report instrument that measures 11 observable
behaviors indicating activity and emotional states. Ratings
are made for observations made over the preceding 7
days. The scale was developed to be administered by a
technician to nursing home personnel. Items are rated on
a 5-point Likert scale and it takes 5 minutes of administra-
tion time.
The scale was evaluated in 42 residents of a dementia spe-
cial care unit. Respondents were required to have 30 or
more hours of exposure to patients during preceding
week. Internal consistency reliability was reported as good
to excellent (Cronbach's alpha = .77). Inter-item correla-
tions were positive and ranged from .17 to .70. For 19 res-
idents, 2- to 3-day test-retest reliability was .81. InterraterHealth and Quality of Life Outcomes 2003, 1 http://www.hqlo.com/content/1/1/11
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reliability was .83 for 23 of the residents. Validity was as-
sessed by examining correlations between QUALID scores
and several other measures of dementia. There were no
significant correlations between the QUALID and the
MMSE or a measure of basic ADLs, but moderate and sig-
nificant correlations were found with a measure of depres-
sive symptoms (r = .36) and neuropsychiatric symptoms
(r = .40).
Quality of Life-Alzheimer's Disease (QOL-AD) [21,22]
Items for the QOL-AD were selected to reflect domains of
QOL in older adults based on a literature review of QOL
in geriatric populations. Face validity and comprehensive-
ness was ensured by having AD patients, caregivers, non-
demented older adults, and dementia experts review
potential items. The final scale is composed of 13-items
that measure the domains of physical condition, mood,
memory, funcational abilities, interpersonal relation-
ships, ability to participate in meaningful activities, finan-
cial situation, and global assessments of self as a whole
and QOL as a whole. Response options are 4-point multi-
ple choice options (1 = poor, 4 = excellent). Scale scores
range from 13 to 52, with higher scores indicating greater
QOL. Strengths of this scale are its brevity and that it relies
on reports from patients, caregivers, or both. A drawback
is that it relies on a conceptualization of QOL that may be
regarded by some investigators as somewhat broad be-
cause it includes items about memory and functional abil-
ities.
Patients and caregivers typically complete the QOL-AD
separately. Patients are interviewed and caregivers re-
spond to the QOL-AD items on a questionnaire. Compos-
ite scores that combine reports from patients and
caregivers are weighted to favor patient self-report. The pa-
tients' score is multiplied by 2, added to the caregiver
score, and the composite is divided by 3. The scale takes
an average of 10 minutes to administer to patients and
caregivers take less than 10 minutes to complete the ques-
tionnaire [22].
Psychometric properties of the QOL-AD were initially
evaluated in a group of 77 AD outpatients and their car-
egivers [21]. A follow-up study with a larger sample of 177
AD patients was recently published [22]. For both studies,
QOL-AD was rated separately by caregivers and patients.
In the larger study, 155 of the 177 patients interviewed
were able to complete the QOL-AD. Mean MMSE for non-
completers was 4.1 compared to 18.1 for completers
(range 4 – 29), and all patients with MMSE scores above
11 were able to complete the QOL-AD. In addition to
greater cognitive impairment, noncompleters also had
significantly more impairment in basic and instrumental
ADLs.
Internal consistency reliability (Cronbach's alpha) ranges
from .84 to .88 for patients and caregivers [21,22]. Pa-
tient-caregiver agreement for the total score was signifi-
cant in the initial validity study (r = .40, p < .01) and
individual item agreement ranged from .04 (ability to do
chores) to .45 (energy) with a median value of .24 [21].
Agreement was lower in the second study (ICC  = .19;
[22]). One-week test-retest reliability for 30 patients was
acceptable (ICC = .76 for patients and .92 for caregivers
[21]). Moderate levels of cognitive impairment do not ap-
pear to adversely affect internal consistency reliability and
patient-caregiver agreement [21,22].
Validity was indicated by low to moderate correlations be-
tween QOL scores and the MMSE and reports of instru-
mental activities of daily living, depression, and
engagement in pleasant events [21]. Validity of patient
scores in the second study was indicated by correlations
between QOL-AD scores and several measures of domains
hypothesized to be associated with QOL: behavioral com-
petence, psychological status, physical function, and in-
terpersonal environment. There were stronger
associations between caregiver-reported QOL and meas-
ures of these other domains [22].
Quality of Life Assessment Schedule (QOLAS) [23]
A strength of the QOLAS is that it is the only dementia
QOL instrument that is tailored to individual patients and
employs both qualitative and quantitative measurement
approaches. Patients are interviewed and asked to identify
what is important for their QOL and two issues from each
of the following domains are identified: Physical, Psycho-
logical, Social/family, Usual activities, and Cognitive
functioning. Patients then rate how much of a problem s/
he is currently experiencing with regard to each of the 10
issues on a 6-point scale (0 = no problem; 5 = it could not
be worse). Scores range from 0 to 50 with higher scores re-
flecting poorer QOL.
A drawback of the QOLAS is that psychometric properties
have been evaluated in a small sample of patients, to date.
Data were collected from 22 dementia patient-carer dyads
who participated in psychometric evaluation of the QO-
LAS. Carers and patients were interviewed separately. In-
ternal consistency reliability as measured by coefficient
alpha was .78 for patients and caregivers. Construct valid-
ity was indicated by significantly (p < .05) higher patient-
reported QOL for a subgroup of patients with less disabil-
ity in ADLs as compared to patients with more disability.
Agreement between patient-reported QOL scores and
scores on a generic measure of QOL ranged from poor to
good (kappa ranged .09 to .67, Mdn = .45). For caregiver-
reported QOL, kappa values ranged from poor to very
good (range .09 to .82, Mdn = .47).Health and Quality of Life Outcomes 2003, 1 http://www.hqlo.com/content/1/1/11
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Discussion
Several instruments designed specifically to measure QOL
in dementia were introduced within the past 10 years.
These measures vary widely in scale content, type of re-
spondent, method of administration, and population for
which they were developed. The greatest similarity among
the instruments is that their development was strongly in-
fluence by Lawton's model of QOL. The greatest differenc-
es appear to stem from differences in how this model is
implemented.
Differences in Conceptualization of QOL in Dementia
Lawton's model of QOL has undoubtedly been the most
pervasive influence on conceptualizations of QOL in de-
mentia and subsequently on the development of QOL in-
struments. Lawton argued that QOL assessment should
include consideration of subjective and objective factors
[4]. He identified four overarching dimensions that con-
tribute to QOL: (1) psychologic well-being (e.g., positive
and negative affect), (2) behavioral competence (e.g., cog-
nitive and functional abilities), (3) objective environment
(e.g., caretakers and living situation), and (4) perceived
QOL [3].
Authors of dementia QOL scales have used different
methods to implement the model. Some investigators
have interpreted these four factors as defining features of
QOL (e.g., [21]), whereas others have viewed some factors
as predictors of QOL and others as indicators of QOL
(e.g., [14,18]). For example, some instruments incorpo-
rate items about functional and cognitive impairment in
the scale, whereas others see these factors as potential pre-
dictors of QOL, but not as defining features. Some authors
noted that including items about cognition and physical
functioning in QOL measures is problematic because
these domains inevitably decline with advancing demen-
tia. Thus, including items about cognition and function-
ing in a QOL scale means that QOL also will inevitably
decline with greater dementia severity [11]. Instruments
that are the most broad and incorporate objective and
subjective indicators of QOL are the QOL-AD and the
QOLAS. The other QOL instruments focus more narrowly
on two or more of the following dimensions: affect, activ-
ity, enjoyment, self-esteem, and social interactions.
Type of Respondent
Another critical dimension along which dementia QOL
instruments vary is whether or not patients participate in
the assessment. This is a critical factor because of the high-
ly subjective nature of QOL assessments. As indicated in
Table 1, authors of four QOL scales made efforts to incor-
porate patients' input in their QOL ratings [14,18,21,31].
Three of these scales [18] also incorporates caregiver in-
put, but two scales weight patients' responses more than
caregivers in creating a composite measure of QOL [21].
The remaining five scales rely solely on proxy reports to
assess QOL.
The two central issues that authors considered in deciding
whether or not to incorporate patients' input into rating
their QOL were cognitive impairment and lack of aware-
ness, both of which are common in dementia. Cognitive
impairment is a diagnostic criteria for dementia [32] and
increases in severity as dementia progresses. Patients even-
tually lose the ability to communicate effectively. Thus,
measures of QOL for patients in the moderate to severe
stages of the disease must inevitably rely more on proxy
reports than on patient self-report. However, for patients
in the mild to moderate stages of dementia, evidence from
several studies indicates that they can provide QOL ratings
that demonstrate adequate reliability and validity
[14,18,21,23]. The most important requirement for ob-
taining reliable data from elderly individuals with cogni-
tive impairment may not be overall level of cognitive
impairment but rather orientation, attention, and lan-
guage skills [33].
Some investigators recognize the limitations of conduct-
ing assessments with dementia patients and have deliber-
ately designed questionnaires to accommodate this
unique population. For example, Brod et al. developed a
brief questionnaire, with simple items, and a visually-me-
diated response scale [18] and Selai et al. incorporated
time to establish good rapport with patients before assess-
ing their QOL [23].
Loss of insight and awareness is common in dementia
[34–36], and this fact raises concerns about the validity of
data that is provided by individuals diagnosed with de-
mentia. However, there is evidence to suggest that aware-
ness of impairments varies across modalities in dementia
[37]. Brod et al. argue that since loss of awareness is not a
unitary phenomena in dementia, it is possible that aware-
ness of cognitive impairment may be distinct from aware-
ness of one's own feeling states. Thus, patients may be
able to report reliably on their QOL, even when they have
poor insight into the severity of their dementia.
Establishing the Validity of QOL Measures
Establishing the validity of QOL measures is perhaps the
most challenging aspect of scale development. Investiga-
tors approached the issue in different ways that are reveal-
ing about their conceptualizations of QOL in dementia.
For example, some authors used indicators of disease se-
verity to validate QOL scores [12], implying that QOL
should decrease with increasing dementia severity.
Depression and mood measures were often used to vali-
date QOL scores [14,18], but other factors included activ-
ities of daily living [23] and generic QOL measuresHealth and Quality of Life Outcomes 2003, 1 http://www.hqlo.com/content/1/1/11
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[16,23]. Several authors used combinations of many fac-
tors to establish the validity of their instrument [19–21].
Without a gold standard against which to compared QOL
assessments, a multimodal approach is probably the best
strategy to establish construct validity of new instruments.
Future Directions
An important issue to address is whether dementia QOL
measures are sensitive to change over time. A measure's
sensitivity to change is critical to evaluating response to
treatment and to determine the effects of disease progres-
sion on QOL. Alert et al. reported that one of their moti-
vations for developing a dementia QOL measure was to
develop an instrument that might be sensitive to changes
in severe and late-stage dementia, when scores on meas-
ures of dementia severity have bottomed-out [12]. Thus,
future longitudinal studies will need to evaluate whether
or not QOL measures are sensitive to clinically meaning-
ful change over time.
More research is needed to identify characteristics of pa-
tients, caregivers, and staff that may affect QOL reports
about patients. For example, patients with more severe
cognitive and functional impairment had more difficulty
reporting on their QOL than patients who were somewhat
higher functioning [22]. Another factor that may interfere
with self-reports is lack of insight, which is common in de-
mentia and increases with dementia severity [36,38,39].
However, little is known about if and when lack of insight
may compromise the validity and reliability of patient
self-reports. In addition, there are several caregiver factors,
such as depression and burden that may affect their re-
ports of patient QOL. In a longitudinal study, Burgener
and Twigg (2002) found that caregiver depression and
burden were correlated with caregiver-reported QOL [7].
It is not clear if caregiver factors caused lower patient
QOL, are simply correlated with patient QOL, or may
have biased their reports of patient QOL. Logsdon et al.
(2002) also reported that caregiver burden was correlated
more strongly with caregiver-reported QOL relative to pa-
tient-reports [22]. More research is needed to address fac-
tors that may threaten the validity and reliability of data
provided by patients, caregivers, and healthcare profes-
sionals.
More research is also needed regarding the impact of per-
ceived QOL on decisions regarding the care of persons
with dementia. For example, a better understanding of
how caregiver reports of patient QOL determine decisions
for residential care planning and use of formal and infor-
mal respite services is needed. The impact of differences
between caregiver and patient perceptions regarding pa-
tient QOL in decision-making also is needed to determine
the degree to which patient perceptions enter into the de-
cision-making process.
Finally, as measurement of QOL advances, investigators
will be in a better position to develop and evaluate inter-
ventions to maintain and enhance QOL for persons with
dementia. Data regarding the effectiveness of medical, so-
cial, behavioral, and environmental interventions for
maximizing patient QOL are needed to help guide re-
source allocation for the optimal care of dementia pa-
tients.
Conclusion
The importance of considering QOL in dementia can not
be overstated. It is of the utmost importance to patients
and their families [40]. Furthermore, for patients diag-
nosed with chronic neurodegenerative disease, healthcare
professionals might have a better ability to intervene to
improve QOL than to change other aspects of the disease
[18]. Assessment of QOL also has the important effect of
calling attention to positive states and 'personhood' in de-
mentia, in contrast to most other measures of dementia
that focus on deficits and pathology [3].
Great strides have been made in recent years to conceptu-
alize, define, and systematically measure QOL in demen-
tia. A range of instruments with promising preliminary
psychometric data are now available for dementia pa-
tients with a range of disease severity. Important direc-
tions for future research on QOL in dementia are to
establish if measures are responsive to change over time,
identify factors that affect reports of QOL, determine the
effect of QOL perceptions on decisions regarding the care
of dementia patients, and evaluate interventions to in-
crease patient QOL.
Authors' Contributions
RER conducted the literature review, wrote summaries of
the QOL instruments, and contributed to the comparison
and critique of the instruments.
BRO contributed the preparation of the manuscript for
publication and participated in the description, compari-
son and critique of instruments.
Both authors read and approved the final manuscript.Health and Quality of Life Outcomes 2003, 1 http://www.hqlo.com/content/1/1/11
Page 8 of 9
(page number not for citation purposes)
Additional material
Acknowledgements
The project was supported by National Institutes of Health – National In-
stitute of Aging postdoctoral fellowship 1F32AG20008-01 (RER). We thank 
Rebecca Logsdon, Ph.D. for her review of this manuscript and for her in-
sightful comments, especially regarding future directions for work to ad-
vance the field of QOL measurement in dementia.
References
1. Small GW, Rabins PV, Barry PP, Buckholtz NS, DeKosky ST, Ferris
SH, Finkel SI, Gwyther LP, Khachaturian ZS, Lebowitz BD, McRae TD,
Morris JC, Oakley F, Schneider LS, Streim JE, Sunderland T, Teri LA
and Tune LE Diagnosis and treatment of Alzheimer disease
and related disorders:  Consensus statement of the Ameri-
can Association for Geriatric Psychiatry, the Alzheimer's As-
sociation, and the American Geriatrics Society Journal of the
American Medical Association 1997, 267:1363-1371
2. Whitehouse PJ, Orgogozo JM, Becker RE, Gauthier S, Pontecorvo M,
Erzigkeit H, Rogers S, Mohs RC, Bodick N, Bruno G and Dal-Bianco
P Quality-of-Life assessment in dementia drug development:
Position paper from the International Working Group on
Harmonization of Dementia Drug Guidelines Alzheimer Disease
and Associated Disorders 1997, 11:56-60
3. Lawton MP Quality of life in Alzheimer disease Alzheimer Disease
and Associated Disorders 1994, 8(Suppl.6):138-150
4. Lawton MP Assessing quality of life in Alzheimer disease re-
search  Alzheimer Disease and Associated Disorders 1997, 11(Sup-
pl.6):91-99
5. Lawton MP, van Haitsma K, Perkinson M and Ruckdeschel K Ob-
served affect and quality of life in dementia:  Further affirma-
tions and problems Journal of Mental Health and Aging 1999, 5:
6. Demers L, Oremus M, Perrault A, Champoux N and Wolfson C Re-
view of outcome measurement instruments in Alzheimer's
disease drug trials:  Psychometric properties of functional
and quality of life scales Journal of Geriatric Psychiatry and Neurology
2000, 13:170-180
7. Burgener S and Twigg P Relationships among caregiver factors
and quality of life in care recipients with irreversible demen-
tia Alzheimer Disease and Associated Disorders 2002, 16:88-102
8. Marinus J, Ramaker C, van Hilten JJ and Stiggelbout AM Health re-
lated quality of life in Parkinson's disease:  A systematic re-
view of disease specific instruments  Journal of Neurology
Neurosurgery and Psychiatry 2002, 72:241-248
9. Novella JL, Jochum C, Jolly D, Morrone I, Ankri J, Bureau F and Blan-
chard F Agreement between patients' and proxies' reports of
quality of life in Alzheimer's disease Quality of Life Research 2001,
10:443-452
10. Berlowitz DR, Du W, Kazis L and Lewis S Health-related quality
of life in nursing home residents:  Differences in patient and
provider perceptions Journal of the American Geriatric Society 1995,
43:799-802
11. Rabins PV, Kasper JD, Kleinman L, Black BS and Patrick DL Concepts
and methods in the development of the ADRQL:  An instru-
ment for assessing health-related quality of life in persons
with Alzheimer's disease Journal of Mental Health and Aging 1999,
5:33-48
12. Albert SM, Castillo-Castaneda CD, Sano M, Jacobs DM, Marder K,
Bell K, Bylsma F, Lafleche G, Brandt J, Albert M and Stern Y Quality
of life in patients with Alzheimer's disease as reported by pa-
tient proxies. Journal of the American Geriatrics Society 1996, 44:1342-
1347
13. Albert SM, Castillo-Castanada C, Jacobs DM, Sano M, Bell K, Mer-
chant C, Small S and Stern Y Proxy-reported quality of life in
Alzheimer's patients:  Comparison of clinical and popula-
tion-based samples Journal of Mental Health and Aging 1999, 5:49-58
14. Ready RE, Ott BR, Grace J and Fernandez I The Cornell-Brown
Scale for Quality of Life in Dementia Alzheimer Disease and Asso-
ciated Disorders 2002, 16:109-115
15. Fossey J, Lee L and Ballard C Dementia Care Mapping as a re-
search tool for measuring quality of life in care setting:  Psy-
chometric properties  International Journal of Geriatric Psychiatry
2002, 17:1064-1070
16. Brooker D, Foster N, Banner A, Payne M and Jackson L The efficacy
of Dementia Care Mapping as an audit tool:  Report of a 3-
year British NHS evaluation Aging & Mental Health 1998, 2:60-70
17. Beavis D, Simpson S and Graham I A literature review of demen-
tia care mapping:  methodological considerations and effica-
cy Journal of Psychiatric and Mental Health Nursing 2002, 9:725-736
18. Brod M, Stewart AL, Sands L and Walton P Conceptualization and
measurement of quality of life in dementia:  The dementia
quality of life instrument (DQoL) The Gerontologist 1999, 39:25-
35
19. Burgener SC, Twigg P and Thorlton J Measuring Psychological
Well-Being in Cognitively Impaired Persons Gerontological Soci-
ety of America Boston November, 2002
20. Weiner MF, Martin-Cook K, Svetlik DA, Saine K, Foster B and Fon-
taine CS The Quality of Life in Late-Stage Dementia (QUAL-
ID) Scale Journal of the American Medical Directors Association 2000,
1:114-116
21. Logsdon RG, Gibbons LE, McCurry SM and Teri L Quality of life in
Alzheimer's disease:  Patient and caregiver reports Journal of
Mental Health and Aging 1999, 5:21-32
22. Logsdon RG, Gibbons LE, McCurry SM and Teri L Assessing quality
of life in older adults with cognitive impairment Psychosomatic
Medicine 2002, 64:510-519
23. Selai CE, Trimble MR, Rossor M and Harvey RJ Assessing quality of
life in dementia:  Preliminary psychometric testing of the
Quality of Life Assessment Schedule (QOLAS) Neuropsycholog-
ical Rehabilitation 2001, 11:219-243
24. Teri L and Logsdon RG Identifying pleasant activities for Alzhe-
imer's disease patients:  The Pleasant Events Schedule - AD
The Gerontologist 1991, 31:124-127
25. Logsdon RG and Teri L The Pleasant Events Schedule-AD:  Psy-
chometric properties of long and short forms and an investi-
gation of its association to depression and cognition in
Alzheimer's disease patients The Gerontologist 1997, 37:40-45
26. Lawton MP, van Haitsma K and Klapper J Observed affect in nurs-
ing home residents with Alzheimer's disease J Gerontol B Psychol
Sci Soc Sci 1996, 51B:P3-P14
27. Stern Y, Sano M, Paulson J and Mayeux R Modified Mini-Mental
State Examination:  Validity and reliability  Neurology 1987,
37(suppl):179
28. Alexopoulos GS, Abrams RC, Young RC and Shamoian CA Use of
the Cornell Scale in nondemented patients Journal of the Amer-
ican Geriatric Society 1988, 36:230-236
29. Alexopoulos GS, Abrams RC, Young RC and Shamoian CA Cornell
Scale for depression in dementia  Biological Psychiatry 1988,
23:271-284
30. Blau TH Quality of life, social indicators, and criteria for
change 1977, 464-473
31. Selai CE, Trimble MR, Rossor MN and Harvey RJ The Quality of
Life Assessment Schedule (QOLAS) - A new method for as-
sessing quality of life in dementia Assessing Quality of Life in Alzhe-
imer's Disease (Edited by: Albert SM and Logsdon RG) New York, NY,
Springer Publishing Company 2000, 31-48
32. Association American Psychiatric The Diagnostic and Statistical
Manual, 4th edition Washington D.C., American Psychiatric Association
1994, 
33. Mozley CG, Huxley P, Sutcliffe C, Bagley H, Burns A, Challis D and
Cordingley L 'Not knowing where I am doesn't mean I don't
know what I like':  Cognitive impairment and quality of life
responses in elderly people International Journal of Geriatric Psychi-
atry 1999, 14:776-783
34. Sevush S and Leve N Denial of memory deficit in Alzheimer's
disease American Journal of Psychiatry 1993, 150:748-751
Additional file 1
Table 1
Click here for file
[http://www.biomedcentral.com/content/supplementary/1477-
7525-1-11-S1.doc]Publish with BioMed Central    and   every 
scientist can read your work free of charge
"BioMed Central will be the most significant development for 
disseminating the results of biomedical research in our lifetime."
Sir Paul Nurse, Cancer Research UK
Your research papers will be:
available free of charge to the entire biomedical community
peer reviewed and published  immediately upon acceptance
cited in PubMed and archived on PubMed Central 
yours — you keep the copyright
Submit your manuscript here:
http://www.biomedcentral.com/info/publishing_adv.asp
BioMedcentral
Health and Quality of Life Outcomes 2003, 1 http://www.hqlo.com/content/1/1/11
Page 9 of 9
(page number not for citation purposes)
35. Lopez OL, Becker JT, Somsak D, Dew MA and DeKosky ST Aware-
ness of cognitive deficits and anosognosia in probable Alzhe-
imer's disease European Neurology 1994, 34:277-282
36. Ott BR, Lafleche G, Whelihan WM, Buongiorno GW, Albert MS and
Fogel BS Impaired awareness of deficits in Alzheimer's dis-
ease Alzheimer Disease and Associated Disorders 1996, 10:68-76
37. Green J, Goldstein FC, Sirochman BE and Green RC Variable
awareness of deficits in Alzheimer's disease Neuropsychiatry,
Neuropsychology, and Behavioral Neurology 1993, 6:159-165
38. Starkstein SE, Chemerinski E, Sabe L, Kuzis G, Petracca G, Teson A
and Leiguarda R Prospective longitudinal study fo depression
and anosognosia in Alzheimer's disease. British Journal of Psychi-
atry 1997, 171:47-52
39. Feher EP, Mahurin RK, Inbody SB, Crook TH and Pirozzolo FJ Ano-
sognosia in Alzheimer's disease Neuropsychiatry, Neuropsychology,
and Behavioral Neurology 1991, 4:136-146
40. Gwyther LP The perspective of the person with Alzheimer
disease:  Which outcomes matter in early to middle stages
of dementia  Alzheimer Disease and Associated Disorders 1997,
11(Suppl6):18-24